Compare Cresco Labs, Inc. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 6.77%
- The company has been able to generate a Return on Capital Employed (avg) of 6.77% signifying low profitability per unit of total capital (equity and debt)
2
Negative results in Dec 24
3
Risky -
4
Below par performance in long term as well as near term
Stock DNA
Other Agricultural Products
CAD 620 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.83
-4.15%
1.04
Revenue and Profits:
Net Sales:
226 Million
(Quarterly Results - Jun 2025)
Net Profit:
-19 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-75.58%
0%
-75.58%
6 Months
-66.44%
0%
-66.44%
1 Year
-76.03%
0%
-76.03%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Cresco Labs, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.38%
EBIT Growth (5y)
23.15%
EBIT to Interest (avg)
0.30
Debt to EBITDA (avg)
2.88
Net Debt to Equity (avg)
0.72
Sales to Capital Employed (avg)
0.74
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
6.77%
ROE (avg)
0.45%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.11
EV to EBIT
9.19
EV to EBITDA
5.43
EV to Capital Employed
1.06
EV to Sales
1.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.57%
ROE (Latest)
-5.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 18 Foreign Institutions (0.15%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
226.40
237.80
-4.79%
Operating Profit (PBDIT) excl Other Income
55.60
40.60
36.95%
Interest
18.60
22.40
-16.96%
Exceptional Items
-13.80
0.00
Consolidate Net Profit
-19.20
-21.90
12.33%
Operating Profit Margin (Excl OI)
159.80%
82.00%
7.78%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -4.79% vs -3.33% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 12.33% vs -3,750.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
992.30
1,040.50
-4.63%
Operating Profit (PBDIT) excl Other Income
241.70
178.80
35.18%
Interest
80.70
85.40
-5.50%
Exceptional Items
-3.30
-202.70
98.37%
Consolidate Net Profit
-82.90
-242.70
65.84%
Operating Profit Margin (Excl OI)
152.40%
82.00%
7.04%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -4.63% vs -5.15% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 65.84% vs 13.63% in Dec 2023
About Cresco Labs, Inc. 
Cresco Labs, Inc.
Other Agricultural Products
Cresco Labs Inc., formerly Randsburg International Gold Corp., is a cannabis operator in United States. The Company manufactures a suite of cannabis extracts and vape products. The Company is a processor and retailer of cannabis products with operations in six states, including Illinois, Ohio, Pennsylvania, Nevada, California and Arizona. It distributes its cannabis products to dispensaries.
Company Coordinates 
Company Details
400 W ERIE ST SUITE 110 , CHICAGO IL : 60654
Registrar Details






